Showing results (571-580 of 777) with videos related to

Sort By:
Pageof 78
The Prostate|May 16, 2018
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63Alba Torres, Mohammed Alshalalfa, Elai Davicioni, et al.
The Journal of Urology|November 17, 2016
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific MortalityWon Sik Ham, Heather J Chalfin, Zhaoyong Feng, et al.
Human Pathology|October 23, 2012
Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladderNilda D Gonzalez-Roibon, Alcides Chaux, Turki Al-Hussain, et al.
Pathology|July 8, 2008
The Symphony protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a multicentre analysis of 120 casesAdeboye O Osunkoya, Donna E Hansel, Anil V Parwani, et al.
The Journal of Urology|February 16, 2005
Serum leptin and pathological findings at the time of radical prostatectomyStephen J Freedland, Lori J Sokoll, Leslie A Mangold, et al.
The Journal of Urology|November 25, 2003
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?Masood A Khan, H Ballentine Carter, Jonathan I Epstein, et al.
The American Journal of Surgical Pathology|December 3, 2008
Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasmMahul B Amin, Ruta Gupta, Hes Ondrej, et al.
Pageof 78